机构:[1]Center for Reproductive Medicine, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, People's Republic of China广东省中医院[2]Institute of Gynecology and Obstetrics, Guangzhou Medical University Second Affiliated Hospital, Guangzhou 510260, People's Republic of China[3]Second School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510020, People's Republic of China广东省中医院
Objective: The present study aimed to evaluate insulin-like growth factor 2 antisense (IGF2-AS) in the villi of human embryos and compared its expression between normal pregnancy and early pregnancy loss (EPL). Materials and methods: The present study conducted a microarray analysis to identify the expression profiles of lncRNAs in villi from EPL and normal controls (controls, n = 10 and EPL patients, n = 10). Embryonic villi were collected from women who underwent artificial abortion. QPCR was used to confirm the results. The DNA methylation patterns were analyzed using pyrosequencing and bisulfite sequencing polymerase chain reaction. The percentage of methylation was compared in chorionic villi from the two groups. Results: A total of 57 deregulated differentially expressed lncRNAs were detected, of which 33 were upregulated, and 24 were downregulated. The expression of lncRNA IGF2-AS was downregulated significantly in EPL villi compared with the normal villi. Negative regulation of IGF2-AS may be involved in the development of EPL. Methprimer predicted that IGF2-AS promoter had CpG islands and dense CG sites. Increased methylation at CpG islands present in IGF2-AS gene promoter was observed in EPL villi. Conclusion: An increase in methylation of IGF2-AS likely leads to its downregulation in chorionic villi of EPL. The findings suggest that a deficiency of IGF2-AS in the villi is associated with human EPL. (C) 2020 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81601280]
第一作者机构:[1]Center for Reproductive Medicine, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, People's Republic of China[2]Institute of Gynecology and Obstetrics, Guangzhou Medical University Second Affiliated Hospital, Guangzhou 510260, People's Republic of China[*1]Center for Reproductive Medicine, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, People's Republic of China
通讯作者:
通讯机构:[1]Center for Reproductive Medicine, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, People's Republic of China[2]Institute of Gynecology and Obstetrics, Guangzhou Medical University Second Affiliated Hospital, Guangzhou 510260, People's Republic of China[*1]Center for Reproductive Medicine, Guangdong Hospital of Traditional Chinese Medicine, Guangzhou 510120, People's Republic of China
推荐引用方式(GB/T 7714):
Wu Ai-Hua,Guo Long-Yi,Lu Shan,et al.Aberrant methylation of IGF2-AS promoter in early pregnancy loss[J].TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY.2020,59(1):109-114.doi:10.1016/j.tjog.2019.11.017.
APA:
Wu, Ai-Hua,Guo, Long-Yi,Lu, Shan,Chen, Xu-Long,Wang, Ai-Ai...&Liang, Xue-Fang.(2020).Aberrant methylation of IGF2-AS promoter in early pregnancy loss.TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY,59,(1)
MLA:
Wu, Ai-Hua,et al."Aberrant methylation of IGF2-AS promoter in early pregnancy loss".TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY 59..1(2020):109-114